1. Neuroscience
Download icon

A statistical framework to assess cross-frequency coupling while accounting for confounding analysis effects

  1. Jessica K Nadalin
  2. Louis-Emmanuel Martinet
  3. Ethan B Blackwood
  4. Meng-Chen Lo
  5. Alik S Widge
  6. Sydney S Cash
  7. Uri T Eden
  8. Mark A Kramer  Is a corresponding author
  1. Boston University, United States
  2. Massachusetts General Hospital, United States
  3. University of Minnesota, United States
Tools and Resources
  • Cited 3
  • Views 2,515
  • Annotations
Cite this article as: eLife 2019;8:e44287 doi: 10.7554/eLife.44287

Abstract

Cross frequency coupling (CFC) is emerging as a fundamental feature of brain activity, correlated with brain function and dysfunction. Many different types of CFC have been identified through application of numerous data analysis methods, each developed to characterize a specific CFC type. Choosing an inappropriate method weakens statistical power and introduces opportunities for confounding effects. To address this, we propose a statistical modeling framework to estimate high frequency amplitude as a function of both the low frequency amplitude and low frequency phase; the result is a measure of phase-amplitude coupling that accounts for changes in the low frequency amplitude. We show in simulations that the proposed method successfully detects CFC between the low frequency phase or amplitude and the high frequency amplitude, and outperforms an existing method in biologically-motivated examples. Applying the method to in vivo data, we illustrate how CFC evolves during seizure and is affected by electrical stimuli.

Data availability

In vivo human data available at https://github.com/Eden-Kramer-Lab/GLM-CFCIn vivo rat data available at https://github.com/tne-lab/cl-example-data

Article and author information

Author details

  1. Jessica K Nadalin

    Department of Mathematics and Statistics, Boston University, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Louis-Emmanuel Martinet

    Department of Neurology, Massachusetts General Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Ethan B Blackwood

    Department of Psychiatry, University of Minnesota, Minneapolis, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3049-0640
  4. Meng-Chen Lo

    Department of Psychiatry, University of Minnesota, Minneapolis, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3913-3233
  5. Alik S Widge

    Department of Psychiatry, University of Minnesota, Minneapolis, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8510-341X
  6. Sydney S Cash

    Department of Neurology, Massachusetts General Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Uri T Eden

    Department of Mathematics and Statistics, Boston University, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Mark A Kramer

    Department of Mathematics and Statistics, Boston University, Boston, United States
    For correspondence
    mak@bu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9979-7202

Funding

National Science Foundation (NSF DMS #1451384)

  • Jessica K Nadalin
  • Mark A Kramer

National Science Foundation (GRFP)

  • Jessica K Nadalin

National Institutes of Health (R21 MH109722)

  • Alik S Widge

National Institutes of Health (R01 EB026938)

  • Alik S Widge
  • Uri T Eden
  • Mark A Kramer

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The animal experimentation received IACUC approval from the University of Minnesota (IACUC Protocol # 1806-36024A).

Human subjects: All patients were enrolled after informed consent, and consent to publish, was obtained and approval was granted by local Institutional Review Boards at Massachusetts General Hospital and Brigham Women's Hospitals (Partners Human Research Committee), and at Boston University according to National Institutes of Health guidelines (IRB Protocol # 1558X).

Reviewing Editor

  1. Frances K Skinner, Krembil Research Institute, University Health Network, Canada

Publication history

  1. Received: December 12, 2018
  2. Accepted: October 6, 2019
  3. Accepted Manuscript published: October 16, 2019 (version 1)
  4. Version of Record published: October 30, 2019 (version 2)

Copyright

© 2019, Nadalin et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,515
    Page views
  • 418
    Downloads
  • 3
    Citations

Article citation count generated by polling the highest count across the following sources: PubMed Central, Crossref, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Biochemistry and Chemical Biology
    2. Neuroscience
    Andrea Loreto et al.
    Research Article

    Axon loss underlies symptom onset and progression in many neurodegenerative disorders. Axon degeneration in injury and disease is promoted by activation of the nicotinamide adenine dinucleotide (NAD)-consuming enzyme SARM1. Here, we report a novel activator of SARM1, a metabolite of the pesticide and neurotoxin vacor. Removal of SARM1 completely rescues mouse neurons from vacor-induced neuron and axon death in vitro and in vivo. We present the crystal structure the Drosophila SARM1 regulatory domain complexed with this activator, the vacor metabolite VMN, which as the most potent activator yet know is likely to support drug development for human SARM1 and NMNAT2 disorders. This study indicates the mechanism of neurotoxicity and pesticide action by vacor, raises important questions about other pyridines in wider use today, provides important new tools for drug discovery, and demonstrates that removing SARM1 can robustly block programmed axon death induced by toxicity as well as genetic mutation.

    1. Neuroscience
    Simon A Sharples, Gareth B Miles
    Research Article Updated

    The size principle underlies the orderly recruitment of motor units; however, motoneuron size is a poor predictor of recruitment amongst functionally defined motoneuron subtypes. Whilst intrinsic properties are key regulators of motoneuron recruitment, the underlying currents involved are not well defined. Whole-cell patch-clamp electrophysiology was deployed to study intrinsic properties, and the underlying currents, that contribute to the differential activation of delayed and immediate firing motoneuron subtypes. Motoneurons were studied during the first three postnatal weeks in mice to identify key properties that contribute to rheobase and may be important to establish orderly recruitment. We find that delayed and immediate firing motoneurons are functionally homogeneous during the first postnatal week and are activated based on size, irrespective of subtype. The rheobase of motoneuron subtypes becomes staggered during the second postnatal week, which coincides with the differential maturation of passive and active properties, particularly persistent inward currents. Rheobase of delayed firing motoneurons increases further in the third postnatal week due to the development of a prominent resting hyperpolarization-activated inward current. Our results suggest that motoneuron recruitment is multifactorial, with recruitment order established during postnatal development through the differential maturation of passive properties and sequential integration of persistent and hyperpolarization-activated inward currents.